Endo Follows Valeant’s Strategy Of Growth Through Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
The specialty pharma’s CFO highlighted Endo’s recent restructuring and talked about its plans for M&A going forward at a recent health care conference.